1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-5-[(trifluoroacetyl)amino]-3-quinolinecarboxylic acid | 115904-56-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-5-[(trifluoroacetyl)amino]-3-quinolinecarboxylic acid
• 英文别名: 1-cyclopropyl-6,7,8-trifluoro-4-oxo-5-[(2,2,2-trifluoroacetyl)amino]quinoline-3-carboxylic acid
• CAS: 115904-56-8
• 化学式: C₁₅H₈F₆N₂O₄
• 分子量: 394.23
• InChiKey: MXGCXTPTAPTLBJ-UHFFFAOYSA-N

物化性质

• 熔点：
  188 °C
• 沸点：
  503.7±50.0 °C(predicted)
• 密度：
  1.822±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  86.7
• 氢给体数：
  2
• 氢受体数：
  11

反应信息

• 作为反应物：
  描述：

  1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-5-[(trifluoroacetyl)amino]-3-quinolinecarboxylic acid 生成 1-Cyclopropyl-6,7,8-trifluoro-1,4-dihydro-5-(methylamino)-4-oxo-3-quinolinecarboxylic acid
  参考文献：
  名称：

  DOMAGALA, JOHN M.;MICH, F.;THOMAS, SANCHER SANCHEZ P.

  摘要：

  DOI：
• 作为产物：
  描述：

  1-环丙基-5-硝基-6,7,8-三氟-1,4-二氢-4-氧代-3-喹啉羧酸乙酯 在 1.) RaNi 盐酸 、 氢气 作用下， 生成 1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-5-[(trifluoroacetyl)amino]-3-quinolinecarboxylic acid
  参考文献：
  名称：

  7-取代的5-氨基-1-环丙基-6,8-二氟-1,4-二氢-4-氧代-3-喹啉羧酸：一类新型喹诺酮抗菌剂的合成和生物活性。

  摘要：

  DOI：

  10.1021/jm00398a003

文献信息

• 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
  申请人：Warner-Lambert Company

  公开号：US04771055A1

  公开（公告）日：1988-09-13

  Novel, orally active antibacterial agents are described and characterized as 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-6-fluoro-1,4-dihydro-4-oxo -3-quinoline carboxylic acids or corresponding 1,8-naphthyridine derivatives as well as methods for their manufacture.

  描述和表征了一种新型口服活性抗菌剂，其为7-[[3-(氨甲基)-3-烷基]-1-吡咯啉基]-6-氟-1,4-二氢-4-氧基-3-喹啉羧酸或相应的1,8-萘啶衍生物，并提供了它们的制备方法。
• 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial
  申请人：Warner-Lambert Company

  公开号：US04822801A1

  公开（公告）日：1989-04-18

  Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.

  本文介绍了新型萘啶、喹啉和苯并噁嗪羧酸作为抗菌剂，以及它们的制备、配方和用于治疗细菌感染的方法，包括用于制备抗菌剂的某些新型中间体的描述。
• Antibacterial agents - II
  申请人：Warner-Lambert Company

  公开号：US05097032A1

  公开（公告）日：1992-03-17

  Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.

  本文描述了新型萘啶、喹啉和苯并噁嗪羧酸作为抗菌剂，以及其制备、配方和治疗细菌感染的使用方法，包括制备抗菌剂所使用的某些新型中间体的描述。
• Substituted-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids, derivatives thereof, pharmaceutical compositions comprising the compounds, and processes for producing the compounds
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP0265230A1

  公开（公告）日：1988-04-27

  Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids of formula in which Z is are disclosed. The compounds are useful as antibacterial agents. Also disclosed is a process for producing the compounds and a pharmaceutical composition comprising the compounds.

  新颖的萘啶、喹啉和苯并噁嗪羧酸，其式为 其中 Z 为 的新型萘啶-喹啉-和苯并噁嗪羧酸。这些化合物可用作抗菌剂。还公开了生产这些化合物的工艺和包含这些化合物的药物组合物。
• DOMAGALA, JOHN M.;HAGEN, SUSAN E.;SANCHEZ, JOSEPH P.
  作者：DOMAGALA, JOHN M.、HAGEN, SUSAN E.、SANCHEZ, JOSEPH P.

  DOI：——

  日期：——